91 results
Abdominal Aortic Aneurysm (AAA) Management and Surveillance

- Screening should be considered for more than just men
Aortic Aneurysm (AAA ... Ana Casanegra ... Aortic #Aneurysm #AAA ... Vascular #Treatment #Algorithm
Effects of Strokes by Location - Anterior vs Posterior Localization

Anterior Circulation 
 - MCA 
 -
- MCA - ACA ... circulation - ASA ... Neurology #Diagnosis #Table
Autoimmune Hemolytic Anemia (AIHA) - Differential Diagnosis Table

Warm AIHA (48-70%)
Cold AHA (16-32%)
 • Donath-Landsteiner HA (paroxysmal
Autoimmune Hemolytic Anemia ... Differential Diagnosis Table ... (48-70%) Cold AHA ... Autoimmune #Hemolytic #Anemia ... Differential #Diagnosis #Table
Cardiac Valve Replacement - Anticoagulation INR Targets and Antiplatelet by Valve Type

Bioprosthetic valves require at least
plus aspirin (ASA ... 3 months, but ASA ... monotherapy (2017 AHA ... bioprosthetic valve (2017 AHA ... #Target #DOAC #Table
Management of Diabetes Mellitus in Patients With CKD

1. Monitor for changes in BP, serum creatinine, &
FDA recommends, ... ADA/KDIGO Consensus ... Diabetes #CKD #ADA ... #KDIGO #eGFR #Insulin
Autoimmune Hemolytic Anemia (AIHA)

WARM AHA
- Primary - Idiopathics
- Secondary
Infectious
 • Viral- HIV, EBV, HCV, HEV
 •
Autoimmune Hemolytic Anemia ... (AIHA) WARM AHA ... alpha-methyldopa COLD AHA ... Autoimmune #Hemolytic #Anemia ... #Differential #Algorithm
ADA 2020 Diabetes #management #algorithm #treatment
ADA 2020 Diabetes ... #management #algorithm
Aplastic Anemia Summary

 • Definition
 • Pathophysiology
 • DDx: AA vs Hypocellular MDS
 • Expectation
 •
Aplastic Anemia ... Pathophysiology • DDx: AA ... Expectation • Rx Algorithm ... #Aplastic #Anemia
Severity of Aortic Stenosis in Adults 
Current ACC/AHA guidelines recommend cut-off values for Doppler-echocardiographic measurements of
Current ACC/AHA ... aortic valve area (AVA ... >50 mmHg (2) (Table ... combination of an AVA
Mild-to-Moderate Ulcerative Colitis - Management Algorithm
Curcumin:
 • Natural phytochemical from turmeric
 • 2g/day divided in 2-3
liver disease • 5-ASA ... combination PO/PR 5-ASA ... effective • PO 5-ASA ... extended-release 5-ASA ... when switching 5-ASA